Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Cervera, 2011, Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non‐criteria APS Manifestations (II): thrombocytopenia and skin manifestations, Lupus, 20, 174, 10.1177/0961203310395052 Cervera, 2015, Morbidity and mortality in the antiphospholipid syndrome during a 10‐year period: a multicentre prospective study of 1000 patients, Ann Rheum Dis, 74, 1011, 10.1136/annrheumdis-2013-204838 Amengual, 2013, Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome, Mod Rheumatol, 23, 81, 10.3109/s10165-012-0642-9 Artim‐Esen, 2015, The significance and management of thrombocytopenia in antiphospholipid syndrome, Curr Rheumatol Rep, 17, 14, 10.1007/s11926-014-0494-8 Cuadrado, 1997, Thrombocytopenia in the antiphospholipid syndrome, Ann Rheum Dis, 56, 194, 10.1136/ard.56.3.194 Diz‐Kucukkaya, 2001, Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study, Blood, 98, 1760, 10.1182/blood.V98.6.1760 Atsumi, 2005, Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis, Lupus, 14, 499, 10.1191/0961203305lu2145rr Otomo, 2012, Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events, Arthritis Rheum, 64, 504, 10.1002/art.33340 Izak, 2014, Management of thrombocytopenia, F1000Prime Rep, 6, 45, 10.12703/P6-45 Harris, 1987, Evaluation of the anti‐cardiolipin antibody test: report of an international workshop held 4 April 1986, Clin Exp Immunol, 68, 215 Amengual, 1996, Specificity of ELISA for antibody to beta 2‐glycoprotein I in patients with antiphospholipid syndrome, Br J Rheumatol, 35, 1239, 10.1093/rheumatology/35.12.1239 Atsumi, 2000, Association of autoantibodies against the phosphatidylserine–prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant, Arthritis Rheum, 43, 1982, 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2 Pengo, 2009, Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis, J Thromb Haemost, 7, 1737, 10.1111/j.1538-7836.2009.03555.x Neunert, 2011, The American Society of Hematology 2011 evidence‐based practice guideline for immune thrombocytopenia, Blood, 117, 4190, 10.1182/blood-2010-08-302984 Moulis, 2016, Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: a systematic review and meta‐analysis, Autoimmun Rev, 15, 203, 10.1016/j.autrev.2015.11.001 Krause, 2005, The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome, Immunobiology, 210, 749, 10.1016/j.imbio.2005.10.005 Espinola, 2002, Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies, Thromb Haemost, 87, 518, 10.1055/s-0037-1613033 Shi, 2006, Anti‐beta2‐glycoprotein I antibodies in complex with beta2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V, Arthritis Rheum, 54, 2558, 10.1002/art.21968 Galli, 1994, Anti‐glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies, Thromb Haemost, 71, 571, 10.1055/s-0038-1642484 Alliot, 2001, Correction of thrombocytopenia with aspirin in the primary antiphospholipid syndrome, Am J Hematol, 68, 215, 10.1002/ajh.1182 Gomez‐Puerta, 2014, Diagnosis and classification of the antiphospholipid syndrome, J Autoimmun, 48–49, 20, 10.1016/j.jaut.2014.01.006